1. Hypoxia Increases Thyroid Cancer Stem Cell‐Enriched Side Population
   K. Mahkamova et al, 2018, World Journal of Surgery CrossRef
2. Multiple Pluripotent Stem Cell Markers in Human Anaplastic Thyroid Cancer: The Putative Upstream Role of SOX2
   Valeria Carina et al, 2013, Thyroid CrossRef
3. Immune-related gene-based model predicts the survival of colorectal carcinoma and reflected various biological statuses
   Zhengchun Kang et al, 2023, Frontiers in Molecular Biosciences CrossRef
4. Managing anaplastic thyroid carcinoma
   Ejigayehu G Abate et al, 2011, Expert Review of Endocrinology & Metabolism CrossRef
5. Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells
   Si Hyoung Kim et al, 2017, Tumor Biology CrossRef
6. Vitamin D and Colorectal Carcinogenesis
   Argjira Juniku-Shkololli, 2017, A Critical Evaluation of Vitamin D - Clinical Overview CrossRef
7. Thyroid cancer stem cells
   Reigh-Yi Lin, 2011, Nature Reviews Endocrinology CrossRef
8. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer
   Su In Lee et al, 2017, Thyroid CrossRef
9. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells
   Shiyang Shen et al, 2021, Nature Nanotechnology CrossRef
10. Bioluminescent Human Thyrospheres Allow Noninvasive Detection of Anaplastic Thyroid Cancer Growth and Metastases In Vivo
    Ashley N. Reeb et al, 2014, Thyroid CrossRef
11. P-glycoprotein inhibition of drug resistant cell lines by nanoparticles
    Manu Smriti Singh et al, 2016, Drug Development and Industrial Pharmacy CrossRef
12. Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells
    Emilly Schlee Villodre et al, 2017, Molecular Neurobiology CrossRef
13. Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention
    Bee Luan Khoo et al, 2019, British Journal of Cancer CrossRef
14. Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma
    Xinyi Cao et al, 2019, Thyroid CrossRef
15. Fluorouracil selectively enriches stem-like cells in the lung adenocarcinoma cell line SPC
    Mu-mu Shi et al, 2013, Tumor Biology CrossRef
16. Thyroid Cancer Stem Cells – Strategies for Therapeutic Targeting
    Reigh-Yi Lin et al, 2013, Stem Cells and Cancer Stem Cells, Volume 10 CrossRef
17. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma
    Zorica Milošević et al, 2018, Cellular Oncology CrossRef
18. Expression of Stanniocalcin 1 in Thyroid Side Population Cells and Thyroid Cancer Cells
    Suguru Hayase et al, 2015, Thyroid CrossRef
19. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer
    Vahid Haghpanah et al, 2016, Tumor Biology CrossRef
20. The PLK1 Inhibitor GSK461364A Is Effective in Poorly Differentiated and Anaplastic Thyroid Carcinoma Cells, Independent of the Nature of Their Driver Mutations
    Marika A. Russo et al, 2013, Thyroid CrossRef
21. The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
    Wang Yin et al, 2021, Scientific Reports CrossRef
22. Normal vs cancer thyroid stem cells: the road to transformation
    M Zane et al, 2016, Oncogene CrossRef